News Medical on MSN1d
AI model identifies potential risk genes for Parkinson's diseaseResearchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
AZoLifeSciences on MSN1d
Researchers Apply Advanced AI Genetics Models to Study Parkinson's DiseaseResearchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics ...
Brain implants to repair Parkinson’s damage being developed by University of Cambridge researchers
Brain implants that could help repair the pathways damaged by Parkinson’s disease are being developed by University of ...
JUPITER, FL - Jupiter Neurosciences, Inc. (NASDAQ: JUNS), a clinical-stage pharmaceutical company with a market capitalization of $40.39 million, has announced a strategic partnership with Zina ...
Sir Nicholas said he did not think a new law should be open to people ‘who aren’t suffering but who happen to have a ...
Scientists from the University of Liverpool and their global collaborators have highlighted the most effective treatments for ...
Azorobotics on MSN1d
AI Model Advances Parkinson’s ResearchAdvanced AI genetics models reveal key genetic markers and potential drug repurposing for Parkinson's disease, accelerating ...
I Herantis Pharma Plc ("Herantis"), a company developing disease-modifying therapies for Parkinson’s disease, is pleased to announce an ...
The blood–brain barrier is a highly selective shield that protects the brain from harmful substances in the bloodstream.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback